Kumar L - Search Results

1

Versican and its associated molecules: potential diagnostic markers for multiple myeloma.

Gupta N, Khan R, Kumar R, Kumar L, Sharma A. Gupta N, et al. Among authors: kumar r, kumar l. Clin Chim Acta. 2015 Mar 10;442:119-24. doi: 10.1016/j.cca.2015.01.012. Epub 2015 Jan 23. Clin Chim Acta. 2015. PMID: 25623955

2

High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.

Kumar L, Raju GM, Ganessan K, Shawgi S, Menon H, Wadhwa J, Sharma A, Singh R, Kochupillai V. Kumar L, et al. Natl Med J India. 2003 Jan-Feb;16(1):16-21. Natl Med J India. 2003. PMID: 12715951 Clinical Trial.

3

Study of antioxidant levels in patients with multiple myeloma.

Sharma A, Tripathi M, Satyam A, Kumar L. Sharma A, et al. Among authors: kumar l. Leuk Lymphoma. 2009 May;50(5):809-15. doi: 10.1080/10428190902802323. Leuk Lymphoma. 2009. PMID: 19452319

4

Flow cytometric immunophenotyping and minimal residual disease analysis in multiple myeloma.

Gupta R, Bhaskar A, Kumar L, Sharma A, Jain P. Gupta R, et al. Among authors: kumar l. Am J Clin Pathol. 2009 Nov;132(5):728-32. doi: 10.1309/AJCP1GYI7EHQYUYK. Am J Clin Pathol. 2009. PMID: 19846814

5

Dysregulation in T helper 1/T helper 2 cytokine ratios in patients with multiple myeloma.

Sharma A, Khan R, Joshi S, Kumar L, Sharma M. Sharma A, et al. Among authors: kumar l. Leuk Lymphoma. 2010 May;51(5):920-7. doi: 10.3109/10428191003699563. Leuk Lymphoma. 2010. PMID: 20367137

6

Angiopoietin-2: a potential novel diagnostic marker in multiple myeloma.

Joshi S, Khan R, Sharma M, Kumar L, Sharma A. Joshi S, et al. Among authors: kumar l. Clin Biochem. 2011 Jun;44(8-9):590-5. doi: 10.1016/j.clinbiochem.2011.01.010. Epub 2011 Feb 12. Clin Biochem. 2011. PMID: 21300047

7

Circulating endothelial progenitor cells as potential prognostic biomarker in multiple myeloma.

Bhaskar A, Gupta R, Kumar L, Sharma A, Sharma MC, Kalaivani M, Thakur SC. Bhaskar A, et al. Among authors: kumar l. Leuk Lymphoma. 2012 Apr;53(4):635-40. doi: 10.3109/10428194.2011.628880. Epub 2011 Dec 5. Leuk Lymphoma. 2012. PMID: 21973309

8

Effect of formulated root endophytic fungus Piriformospora indica and plant growth promoting rhizobacteria fluorescent pseudomonads R62 and R81 on Vigna mungo.

Kumar V, Sarma MV, Saharan K, Srivastava R, Kumar L, Sahai V, Bisaria VS, Sharma AK. Kumar V, et al. Among authors: kumar l. World J Microbiol Biotechnol. 2012 Feb;28(2):595-603. doi: 10.1007/s11274-011-0852-x. Epub 2011 Jul 28. World J Microbiol Biotechnol. 2012. PMID: 22806855

9

Interrelationship and expression profiling of cyclooxygenase and angiogenic factors in Indian patients with multiple myeloma.

Khan R, Sharma M, Kumar L, Husain SA, Sharma A. Khan R, et al. Among authors: kumar l. Ann Hematol. 2013 Jan;92(1):101-9. doi: 10.1007/s00277-012-1572-5. Epub 2012 Sep 13. Ann Hematol. 2013. PMID: 22971811

10

Angiopoietins as biomarker of disease activity and response to therapy in multiple myeloma.

Bhaskar A, Gupta R, Vishnubhatla S, Kumar L, Sharma A, Sharma MC, Das P, Thakur SC. Bhaskar A, et al. Among authors: kumar l. Leuk Lymphoma. 2013 Jul;54(7):1473-8. doi: 10.3109/10428194.2012.745523. Epub 2012 Nov 26. Leuk Lymphoma. 2013. PMID: 23113684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,779 results

Search Page

Filters